Distinct effects of intranigral L-DOPA infusion in the MPTP rat model of Parkinson's disease

J Neural Transm Suppl. 2009:(73):259-68. doi: 10.1007/978-3-211-92660-4_21.

Abstract

The potential neuroprotective or neurotoxic effects of 3,4-dihydroxyphenylalanine (L-DOPA) are yet to be understood. We examined the behavioral, immunohistochemical, tyrosine hydroxylase (TH) expression and neurochemical parameters after an intranigral administration of L-DOPA (10 microM) in rats. L-DOPA elicited a 30.5% reduction in dopaminergic neurons, while 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (100 microg microL(-1)) produced a 53.6% reduction. A combined infusion of MPTP and L-DOPA generated a 42% reduction of nigral neurons. Motor parameters revealed that both the MPTP and L-DOPA groups presented impairments; however, the concomitant administration evoked a partial restorative effect. In addition, MPTP and L-DOPA separately induced reductions of TH protein expression within the substantia nigra. In contrast, the coadministration of MPTP and L-DOPA did not demonstrate such difference. The striatal levels of dopamine were reduced after MPTP or L-DOPA, with an increased turnover only for the MPTP group. In view of such results, it seems reasonable to suggest that L-DOPA could potentially produce dopaminergic neurotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine* / pharmacology
  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Analysis of Variance
  • Animals
  • Antiparkinson Agents / therapeutic use*
  • Cell Count
  • Disease Models, Animal
  • Dopamine / metabolism
  • Drug Interactions
  • Gene Expression Regulation / drug effects
  • Homovanillic Acid / metabolism
  • Levodopa / therapeutic use*
  • Male
  • Movement / drug effects
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurotoxins* / pharmacology
  • Parkinsonian Disorders* / chemically induced
  • Parkinsonian Disorders* / drug therapy
  • Parkinsonian Disorders* / pathology
  • Rats
  • Rats, Wistar
  • Reaction Time / drug effects
  • Substantia Nigra / drug effects*
  • Substantia Nigra / pathology
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Antiparkinson Agents
  • Neurotoxins
  • 3,4-Dihydroxyphenylacetic Acid
  • Levodopa
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Tyrosine 3-Monooxygenase
  • Dopamine
  • Homovanillic Acid